|
|
MARKETS
RECOMMENDATION:
Pfizer (Rs 578.65): Buy
We recommend a buy in Pfizer from a short-term perspective. It is clearly evident from the charts of Pfizer that it was on a long-term downtrend from its 52-week high of Rs 850 (recorded on December 31, 2007) to late September low of Rs ...
RECOMMENDATION:
Day Trading Guide
...
FOREIGN INSTITUTIONAL INVESTORS:
SEBI may ease restrictions on P-Notes
Review prompted by tight liquidity. Mumbai, Oct. 5 The board of Securities and Exchange Board of India, which is scheduled to meet on Monday, is likely to ease the current restrictions on investments by foreign institutional investors (FIIs) ...
OUTLOOK:
Selling pressure likely to continue on Dalal Street
Market lowered its expectation on revenue, earning growth. This week the market is likely to come under selling pressure. Global storm and local concerns are yet to play out fully on Dalal Street. However, substantial resistance would, perhaps, ...
INVESTMENTS:
Slowdown fears begin to impact commodity prices
Gold seems to have fallen out of favour with investors. Fears of global economic slowdown are beginning to take a toll on commodity prices. Apprehensions of slowing world growth have combined with appreciation of the dollar (against the euro) to ...
COMMENTARY:
Most counters hit 52-week lows
Infotech stocks among worst performers. Notwithstanding the $700-billion bailout package getting the Congressional approval, US stocks tumbled the most since the September 2001 terrorist attacks. The Dow Jones Industrial Average of 30 blue-chips ...
STOCKS:
How are share prices determined?
How does the market fix the share price? Sometimes it goes up and sometimes it comes down. Is there a formula for price fixation in the ...
FOREIGN INSTITUTIONAL INVESTORS:
Effect of crisis
I am not able to understand why the Indian stock market should go into a tailspin when an American ...
STOCK MARKETS:
Do you think the positives of Wall Street outweigh the negatives?
Send in your responses, along with your hi-res photo, to: ...
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
|